# American Strategic Investment Co.: overview NYC · NYSE · CIK 1595527 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/nyc.md) · [Financials](/companies/nyc/financials.md) · [Filings](/companies/nyc/filings.md) · [Insiders](/companies/nyc/insiders.md) Latest reported revenue: [$16.2m](/filings/0001595527-23-000013.md) for Q4 FY2022, three months to 2022-12-31, from the 10-K filed Mar 16, 2023 (XBRL us-gaap:Revenues, accession 0001595527-23-000013). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(13.52)](/filings/0001595527-25-000014.md) | not reported | [(3.39)](/filings/0001628280-26-035536.md) | [(16.39)](/filings/0001628280-26-056274.md) | [13.60](/filings/0001595527-25-000014.md) | not reported | [(3.04)](/filings/0001628280-26-035536.md) | [(3.04)](/filings/0001628280-26-056274.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Net income: us-gaap:NetIncomeLoss; Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | [800](/filings/0001628280-25-013880.md) | [700](/filings/0001628280-25-013880.md) | [0.0](/filings/0001628280-25-013880.md) | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | [(3368.1%)](/filings/0001628280-25-013880.md) | [(12443.1%)](/filings/0001628280-26-025292.md) | not reported | not reported | | Net margin | % | not reported | [(5737.0%)](/filings/0001628280-25-013880.md) | [(15132.0%)](/filings/0001628280-26-025292.md) | not reported | not reported | | Diluted EPS | $ per share | [(24.42)](/filings/0001595527-24-000006.md) | [(26.59)](/filings/0001628280-25-013880.md) | [(47.57)](/filings/0001628280-26-025292.md) | [(56.51)](/filings/0001628280-26-025292.md) | [(8.32)](/filings/0001628280-26-025292.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nyc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $202.2k | 20,973 | | Added +188 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $150.6k | 15,617 | | Reduced −3,835 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $112.5k | 11,666 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $16.1k | 1,675 | | Reduced −26 | | [Triumph Capital Management](/funds/1730765.md) | 2026-06-30 | $3.6k | 375 | | Unchanged | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $2.7k | 277 | | New +277 | | [Global Retirement Partners, LLC](/funds/1749744.md) | 2026-06-30 | $1.9k | 193 | | Not compared | | [NFSG Corp](/funds/1879757.md) | 2026-06-30 | $1.5k | 156 | | Unchanged | | [BOKF, NA](/funds/9634.md) | 2026-06-30 | $819 | 85 | | New +85 | | [Blue Trust, Inc.](/funds/1856022.md) | 2026-06-30 | $781 | 81 | | Unchanged | ## Recent filings [All 812 filings](/companies/nyc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-27 | 19:12 ET | [SCHEDULE 13D/A](/filings/0000950142-26-002447.md) | Ownership report, active investor, amended | 0000950142-26-002447 | | 2026-08-12 | 16:35 ET | [10-Q](/filings/0001628280-26-056274.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056274 | | 2026-08-12 | 06:03 ET | [8-K](/filings/0001628280-26-055929.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-055929 | | 2026-08-04 | 06:15 ET | [8-K](/filings/0001104659-26-090004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-090004 | | 2026-07-24 | 16:30 ET | [8-K](/filings/0001104659-26-086661.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-086661 | | 2026-07-13 | 16:58 ET | [8-K](/filings/0001104659-26-083143.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-083143 | | 2026-07-09 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000950142-26-002016.md) | Ownership report, active investor, amended | 0000950142-26-002016 | | 2026-07-02 | 17:00 ET | [SCHEDULE 13D/A](/filings/0000950142-26-001977.md) | Ownership report, active investor, amended | 0000950142-26-001977 | | 2026-06-03 | 16:22 ET | [8-K](/filings/0001104659-26-070118.md) | 5.07 Shareholder vote results | 0001104659-26-070118 | | 2026-05-15 | 16:30 ET | [8-K](/filings/0001104659-26-062629.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-062629 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-025292.md), filed Apr 15, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1595527 - Tickers: NYC - Exchange: NYSE - SIC code: 6798 Real Estate Investment Trusts - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.